WDR37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.980600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.938400E-01
Normal-vs-Stage2
2.891400E-01
Normal-vs-Stage3
2.196200E-01
Normal-vs-Stage4
3.232200E-01
Stage1-vs-Stage2
1.087840E-01
Stage1-vs-Stage3
6.446300E-02
Stage1-vs-Stage4
5.342600E-01
Stage2-vs-Stage3
1.474960E-01
Stage2-vs-Stage4
6.682400E-01
Stage3-vs-Stage4
1.107040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.019200E-01
Normal-vs-AfricanAmerican
3.451000E-01
Normal-vs-Asian
2.238600E-01
Caucasian-vs-AfricanAmerican
5.198600E-01
Caucasian-vs-Asian
2.327700E-02
AfricanAmerican-vs-Asian
2.256400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.974800E-01
Normal-vs-Female
3.008000E-01
Male-vs-Female
8.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.331800E-01
Normal-vs-Age(41-60Yrs)
3.164800E-01
Normal-vs-Age(61-80Yrs)
2.923200E-01
Normal-vs-Age(81-100Yrs)
2.680000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.947200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.871000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.580370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.000600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.744050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.738400E-01
Normal-vs-Daily Drinker
2.642800E-01
Normal-vs-Weekly Drinker
2.791000E-01
Normal-vs-Occasional Drinker
3.194400E-01
Normal-vs-Social Drinker
3.037400E-01
Non Drinker-vs-Daily Drinker
7.679400E-01
Non Drinker-vs-Weekly Drinker
9.060600E-01
Non Drinker-vs-Occasional Drinker
3.815800E-01
Non Drinker-vs-Social Drinker
4.962600E-01
Daily Drinker-vs-Weekly Drinker
6.875800E-01
Daily Drinker-vs-Occasional Drinker
3.102800E-01
Daily Drinker-vs-Social Drinker
3.298200E-01
Weekly Drinker-vs-Occasional Drinker
5.237800E-01
Weekly Drinker-vs-Social Drinker
5.984800E-01
Occasional Drinker-vs-Social Drinker
8.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.528430E-01
Normal-vs-Grade 2
9.541500E-02
Normal-vs-Grade 3
1.447150E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.721590E-01
Grade 1-vs-Grade 3
1.020810E-01
Grade 1-vs-Grade 4
1.528430E-01
Grade 2-vs-Grade 3
5.356800E-01
Grade 2-vs-Grade 4
9.541500E-02
Grade 3-vs-Grade 4
1.447150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.975000E-01
Normal-vs-NonDiabetic
2.825800E-01
Diabetic-vs-NonDiabetic
5.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.505000E-01
Normal-vs-NoPancreatitis
2.905600E-01
Pancreatitis-vs-NoPancreatitis
2.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.201200E-01
Normal-vs-N1
2.874000E-01
N0-vs-N1
2.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.451000E-01
Normal-vs-TP53-NonMutant
3.800000E-01
TP53-Mutant-vs-TP53-NonMutant
4.63080000001614E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
